Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-05-02 00:00:00 ET · period of report 2024-05-01 · accession 0001209191-24-005486 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-05-02 | 2024-05-01 | VKTX | Mancini Marianna | COO | M - OptEx | $6.18 | +281.4K | 366.5K | +331% | +$1.74M |
| DM | 2024-05-02 | 2024-05-01 | VKTX | Mancini Marianna | COO | S - Sale+OE | $78.66 | -281.4K | 354.8K | -44% | -$22.14M |
| DM | 2024-05-02 | 2024-05-01 | VKTX | Mancini Marianna | COO | M - OptEx | $0.00 | -281.4K | 87.0K | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | M | A | 35,426 | $7.77 | 578,933 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | M | A | 51,000 | $8.52 | 629,933 | D | — | — | |
| 3 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | S | D | 23,746 | $76.40 | 606,187 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $76.09 to $76.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | S | D | 26,142 | $77.49 | 580,045 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $77.00 to $77.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 5 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | S | D | 105,343 | $78.65 | 474,702 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $78.00 to $78.9983, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 6 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | M | A | 90,000 | $5.80 | 543,507 | D | — | — | |
| 7 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | S | D | 6,248 | $80.08 | 348,508 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $80.02 to $80.19, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 8 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | S | D | 119,946 | $79.29 | 354,756 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $79.00 to $79.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| 9 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | M | A | 87,000 | $4.88 | 453,507 | D | — | — | |
| 10 | Common | Common Stock, par value $0.00001 per share | 2024-05-01 | M | A | 17,999 | $4.68 | 366,507 | D | — | — | |
| 11 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 17,999 | $0.00 | 1 | D | $4.68 · 2021-03-31 to 2030-03-31 | 17,999 Common Stock | (F7) 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date. |
| 12 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 90,000 | $0.00 | 0 | D | $5.80 · 2022-01-04 to 2031-01-04 | 90,000 Common Stock | (F8) One-third of the shares subject to the option vested on each one year anniversary of the grant date. |
| 13 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 51,000 | $0.00 | 153,000 | D | $8.52 · 2024-01-03 to 2033-01-03 | 51,000 Common Stock | (F7) 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date. |
| 14 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 35,426 | $0.00 | 18,574 | D | $7.77 · 2021-01-03 to 2030-01-03 | 35,426 Common Stock | (F7) 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date. |
| 15 | Derivative | Stock Option (Right to Buy) | 2024-05-01 | M | D | 87,000 | $0.00 | 87,000 | D | $4.88 · 2023-01-03 to 2032-01-03 | 87,000 Common Stock | (F7) 25% of the shares subject to the option vested or will vest on each one year anniversary of the grant date. |